The Hematology Care Coordination team addresses the educational and psychosocial needs of transplantation patients in a multidisciplinary fashion. Central to this formal education plan is the unique partnership of the Oncology-Certified RN Hematology Care Coordinator and Social Worker who assess these needs throughout the continuum of care. The process centers around a patient/caregiver educational meeting, at which time a comprehensive participative needs assessment is completed, goals are developed, and interventions are initiated.
The Hematology Care Coordination team addresses the educational and psychosocial needs of transplantation patients in a multidisciplinary fashion. Central to this formal education plan is the unique partnership of the Oncology-Certified RN Hematology Care Coordinator and Social Worker who assess these needs throughout the continuum of care. The process centers around a patient/caregiver educational meeting, at which time a comprehensive participative needs assessment is completed, goals are developed, and interventions are initiated.
Due to the complexity of the transplantation process, adequate patient and caregiver education is crucial. The Care Coordination team recognized that our current process lacked multidisciplinary coordination. Our purpose was to develop a coordinated assessment process to identify immediate and future educational and psychosocial needs and to develop an educational plan that fosters patient/caregiver empowerment. It was anticipated by our team that this educational program would result in a better understanding and compliance with team recommendations.
It was identified that earlier referrals to the Care Coordination team were necessary. The weekly multidisciplinary bone marrow transplantation meeting now serves as the initial referral to the Care Coordination team. The treatment plan is completed collaboratively by the transplantation team. This plan provides initial insight into the educational and psychosocial needs of the patient/ caregiver.
Before the patient/caregiver meeting, an educational binder is individualized based on transplantation type. This binder guides the format and content of the meeting. A needs assessment to investigate knowledge, financial, and psychosocial issues of the patient/caregiver is performed, and an exclusive teaching plan is immediately initiated. After the meeting, referrals are made to ancillary support services for continued assessment and education. We have found that our up-front assessment and screening followed by individual instruction have contributed to a more successful learning experience. Our patients have verbalized a marked decrease in anxiety and increase in knowledge, which has facilitated a better compliance with the treatment plan. The physicians concur based on assessment of anxiety, knowledge, and understanding on signing the informed consent. This project stresses the importance of the nurse's role in patient education, which can be duplicated in various practice settings. Hurler's syndrome is caused by mutations in the alpha iduronidase gene and results in progressive deterioration of the central nervous system. Allogeneic bone marrow transplantation before age 2 years halts disease progression and prolongs life. Enzyme replacement therapy (ERT) reduces lysosomal storage of mucopolysaccharides in the liver and ameliorates extracranial manifestations of the disease. In most instances, ERT is done in a dayhospital setting. Because enzyme replacement therapy can mitigate airway and pulmonary manifestation of MPS I, we hypothesized that ERT in the peritransplantation period (pre-HSCT and immediately post-HSCT) would decrease transplantation-related complications. We performed combined ERT and HSCT in a 12-month-old boy with MPSI. The patient received his first dose of Aldurazyme at age 5 months, shortly after MPSI diagnosis. He had received 16 infusions before referral to our center. Throughout his pretransplantation workup, the patient received ERT at the local Transplantation House by a visiting nurse. There were no infusionrelated toxicities. The patient received a 5/6 unrelated cord blood unit and engrafted on day ϩ12. Hyperacute GVHD was treated successfully with high-dose methylprednisolone pulse. After engraftment, the child received 8 additional doses of Aldurazyme. Four initial infusions were performed in the pediatric bone marrow transplantation unit following in-service by pediatric BMT nurse and pediatric BMT pharmacist. The remainder of his 4 infusions were performed at the local Transplantation House. We conclude that in this first case of combined outpatient ERT infusion with HSCT, pretransplantation and posttransplantation ERT does not interfere with engraftment. Further studies are needed to determine whether progressive neurodegeneration is altered.
COMBINED HOME ENZYME REPLACEMENT THERAPY AND UNRELATED CORD BLOOD TRANSPLANTATION FOR HURLER'S SYNDROME (MPSI) IN A PEDIATRIC HSCT CENTER

THE NURSING SHORTAGE: THE DUKE PEDIATRIC STEM CELL TRAN-PLANT PROGRAM NURSING RECRUITMENT AND RETENTION PRO-GRAM Frey, M.A., Talbert, G. Duke University Pediatric Stem Cell Transplant Program, Durham, NC.
Health care organizations are in the midst of a severe and profound nursing shortage that is expected to intensify as "baby boomers" age and the need for health care grows. Nursing programs across the country are struggling to expand enrollment levels to meet the rising demand for nursing care. According to the latest projections from the U.S. Department of Labor Statistics published in the February 2004 Monthly Labor Review, more than 1 million new and replacement nurses will be needed by 2012. For the first time, the U.S. Department of Labor has identified registered nursing as the top occupation in terms of job growth through the year 2012. The need for registered nurses has dramatically and negatively impacted patient care. According to a study published in the Journal of the American Medical Association in October 2002, nurses reported greater job dissatisfaction and emotional exhaustion when they were responsible for more patients than they can safely care for. Lead researcher Dr. Linda Aiken concluded that "failure to retain nurses contributes to avoidable patient deaths." Another published study by Dr. Aiken (Health Affairs, May/June 2001) concluded that Ͼ 40% of nurses working in hospitals reported being dissatisfied with their jobs. The study also concluded that 1 of every 3 hospital nurses under age 30 are planning to leave their current job within the next year.
The purpose of this abstract is to describe the Duke Pediatric Stem Cell Transplant Program's Nursing and Retention Program. This program was developed in 1998 in an effort to recruit and retain top talent in a unit that had historically sustained chronic nursing vacany rates Ͼ 30%. Before the inception of this program, the pediatric inpatient unit had to close beds due to the shortage of qualified nurses. Since the implementation of this plan, there is now a waiting list of qualified applicants. The plan involves a fully developed shared governance model, staff involvement in decision making on the unit, and dedicated funding for retention opportunities that support the inpatient nursing staff. Blackstock, J.L., Parikh, S.H., Talbert, J.G. Pediatric Bone Marrow/ Stem Cell Transplant, Duke University Medical Center, Durham, NC. Herpes simplex is a viral infection that usually produces small, temporary irritating, and sometimes painful fluid-filled blisters on the skin and mucous membranes. Primary herpes simplex virus (HSV) infection usually occurs in early childhood, after which time the virus becomes latent. Reactivation is more likely to occur during periods of immunosuppression. Bone marrow and stem cell transplantation recipients' host immune systems are ablated before transplantation, and thus every aspect of the immune system is deficient. HSV infection can be devastating when it occurs in immunocompromised patients. Herpes simplex in patients with compromised immune systems can cause serious, perhaps life-threatening complications. Prophylactic acyclovir is routinely given to patients, which has lessened the prevalence of HSV. When HSV does not respond to acyclovir, or is found to be resistant to acyclovir, foscarnet has proven to be a powerful antiviral agent; however, foscarnet can be very toxic to renal function. This poster will include general information on this virus and treatments used to control it, along with nursing considerations for the care of the pediatric transplantation patient with a reactivation of HSV infection.
HERPES SIMPLEX VIRUS IN THE PEDIATRIC BONE MARROW AND STEM CELL TRANSPLANTATION PATIENT
ASSESSING FOR NUTRITIONAL RISK FACTORS ON A BONE MARROW TRANSPLANTATION UNIT Szewczyk, N.A. University of Texas M.D. Anderson Cancer Center, Houston, TX.
The Assessing for Nutritional Risk Factors clinical project took place in a bone marrow transplantation (BMT) unit in San Antonio, Texas. The purpose of this project is to develop an assessment tool for identifying individuals in a BMT inpatient unit who are at risk for developing complications secondary to inadequate nutritional intake. A secondary goal of this project is to increase nutritional assessment documentation by the nursing staff in this unit. The Nutritional Risk Assessment Tool (NRAT) preevaluation data were obtained by interviewing the staff regarding their opinions about malnutrition in the oncology patient population and the usefulness of the NRAT on the BMT unit. In addition, the documentation rate of calorie counts and weights was collected for the 3 months before this project's implementation.
Results showed a significant increase in calorie count documentation and an overall increase in the staff's awareness about malnutrition in this patient population. The outcomes of this project include (1) increased awareness of nutritional deficits in the BMT population in multidisciplinary team members including RNs, PCAs, and MDs; (2) increased documentation of inadequate dietary assessment; and (3) pilot testing of a nutritional assessment tool. Choi, S.E., Kim, K.S., Bok, G.N. St. Mary's Hospital, Catholic HSCT Center, Seoul, Korea. Hematopoietic stem cell transplantation(HSCT) is a widely used treatments for hematologic malignancies and has often ensured long-term survival of HSCT patients. Concern for "quality of life" in HSCT patients has increased, and a quality of life issue becomes recognized as an important outcome of the treatment. These patients and their families are expecially interested in when they are going to return to "normal" life and how much time it will take. Therefore, we examined post-HSCT patients' subjective symptoms and performance status as indicators of quality of life.
SUBJECTIVE SYMPTOMS AND PERFORMANCE STATUS OF SURVIVORS OF HEMATOPOIETIC STEM CELL TRANSPLANTATION
The final samples consisted of 250 patients who had undergone HSCT at a single center from 1990 to October 2003 and survived at least 1 year after receiving HSCT. Of the 250 patients, 142 were male and 108 were female, with a mean age of 33 years. Of the total patients, 113 patients (59.5%) had been married and 73 patients (38.4%) wre been single at the time of HSCT.
The patients completed a questionnaire mailed by the researchers. Subjective symptom subscales include fatigue, nausea and vomiting, pain, dyspnea, insomnia, loss of appetite, constipation, diarrhea, and financial difficulties. The scores of subjective symptoms range from 0 to 100, with higher scores indicating more severe symptoms. Performance status was measured in patients over age 16 years using the Karnofsky score and in those under age 16 years using the Lansky scale.
The median score of subjective symptom after HSCT was 12.2 (range, 0 -68.8). The subjective symptom which many of the patients complained about was financial difficulties (median, 40), followed by fatigue (median, 30) and insomnia (median, 17.3) . By 3 years, those symptoms had gradually decreased.
The median score of performance status 1-3 years after HSCT was 80%, but 3 years later it was 90%, indicating that as time went on, performance status improved. Among the 114 patients who had been employed before HSCT, 81 (71.1%) continued to work but 30 (26.3%) became unemployed after HSCT. The average time to return to school and work was 1.27 years (range, 1 to 7 years); within 2 years after HSCT, 80 patients (72.7%) returned.
In conclusion, those findings can suggest that until 3 years following HSCT, there should be steady management of physical symptoms and complications which post-HSCT patients possibly experience. Aplastic anemia is a rare, potentially lethal disease that occurs when the bone marrow stops making enough blood cells. The condition results in complete bone marrow failure and aplasia. Common life threatening complications include infection, bleeding, and anemia. The cause of aplastic anemia is unknown but may be linked to injury to the bone marrow from radiation, chemicals, viruses, and other causes. The initial diagnosis of aplastic anemia is often a medical emergency requiring hospitalization and isolation. The diagnosis is typically made via peripheral blood sampling and a bone marrow aspirate. Supportive care during the initial period typically consists of blood component replacement and antimicrobial coverage to reduce and treat life-threatening infections. The gold standard of cure for these patients is bone marrow or stem cell transplantation. The Duke Pediatric Stem Cell Transplant Program has performed 22 transplantations on children with aplastic anemia. The aims ofthis abstract are as follows: Established visitation policies exist to provide a safe environment, yet they may be at odds with the psychological needs of patients. Bone marrow transplantation (BMT) patients experience prolonged neutropenia, resulting in protracted lengths of stay. Families/caregivers wish to show psychological support by increased Transplant Nursing
